CELLDEX THERAPEUTICS, INC. (CLDX)
Clinical trial NCT05029999 updates: 1. completion date: 2026-04-20 → 2029-04-20 2. primary completion date: 2026-04-20 → 2028-04-20 3. collaborators added: National Cancer Institute (NCI) 4. collaborators removed: National Institutes of Health (NIH)
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical